|
CDNA | Caredx, Inc. |
|
|
CDNA | Caredx, Inc. |
| Services-Medical Laboratories |
| Book value per $ invested | $ 0.25 |
| Leverage | 42.71% |
| Market Cap | $ 1.1B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -139.9m |
| Margin | -44.86% |
CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. The company is headquartered in South San Francisco, California.